If a device is used on one patient and then on another, the FDA expects you to prove that everything from the first patient is gone: demonstrated absent to a defined limit using validated methods on a worst-case unit. That proof is reprocessing validation, the most underestimated work package in any reusable device program, because teams budget for sterilization and forget it is the last step of three.
The reason is physical. Sterilization kills organisms; it does not remove blood, tissue, or lubricant. Organic residue shields microorganisms from steam and chemical sterilants, so a device that has not been cleaned effectively cannot be reliably sterilized. Cleaning is the foundation, and validating it is where your product design gets judged.
The three-step chain and what has to be proven
- Cleaning: physical removal of organic and inorganic soil, validated by measuring residual markers on a deliberately over-soiled device after your written procedure.
- Disinfection: inactivation of most microorganisms at a high, intermediate, or low level, validated against defined challenge organisms.
- Sterilization: a validated process delivering a defined sterility assurance level, covered in our comparison of medical device sterilization methods.
Which steps apply depends on Spaulding classification. Critical devices entering sterile tissue or the vascular system require cleaning plus sterilization; semi-critical devices contacting mucous membranes require at least high-level disinfection; non-critical devices contacting intact skin require low-level disinfection. Settle that first, because it sets the validation scope.
The standards a reviewer expects you to have used
| Document | What it gives you |
|---|---|
| FDA reprocessing guidance | Six criteria for reprocessing instructions, plus the expectation that validation data accompany a submission |
| AAMI TIR12 | Design guidance for reusable devices and how to develop reprocessing instructions |
| AAMI TIR30 | Cleaning process validation: test soils, residual markers, extraction methods, acceptance criteria |
| ISO 17664 | What information the manufacturer must supply to the processor |
| ISO 15883 series | Washer-disinfector requirements, if you claim automated reprocessing |
| AAMI ST98 | Cleaning validation expectations for health care facility processing |
The FDA's six criteria are worth memorizing, because deficiency letters quote them directly. Instructions must reflect intended use, be technically feasible in a real facility, include only legally marketed devices and accessories, be comprehensive, be understandable, and be validated.
Worst case is the whole game
Validation is not performed on a clean device given a light soil. It is performed on the worst case in every dimension you can construct.
Worst-case device. The configuration with the longest lumen, narrowest bore, most hinges, most mated surfaces, and roughest finish. If a family shares a design, justify the bracketing rationale in writing.
Worst-case soil. A standardized artificial test soil based on blood or a defined protein, carbohydrate, and lipid mixture, applied to every surface a patient could contaminate including internal channels, then dried under conditions harsher than clinical practice.
Worst-case process. Run the cleaning at the shortest time, lowest temperature, and lowest detergent concentration your instructions permit. If you say five to ten minutes of soaking, you validate at five.
Worst-case wear. Devices are cycled through simulated use and reprocessing many times before the cleaning test, because a scratched, worn surface is harder to clean than a new one.
Residual markers and acceptance criteria
After cleaning, the device is extracted and the extract analyzed for markers standing in for patient material: protein, hemoglobin, total organic carbon, carbohydrate, and where relevant endotoxin or bioburden. Common acceptance limits are on the order of a few micrograms of protein per square centimeter of surface and a lower figure for hemoglobin, with the values justified in your protocol rather than asserted.
Two methodological details separate a protocol that passes review from one that does not. First, extraction efficiency must be established, since you are measuring what came off the device rather than what was on it. Second, at least two independent markers are normally expected, because a single analyte can give a falsely clean answer.
Disinfection efficacy is validated separately, by inoculating the device with defined challenge organisms and demonstrating the required log reduction. Reduced-cycle approaches are common for building in margin.
Design decisions that make validation possible or impossible
Most reprocessing failures are designed in, and they are far cheaper to fix in CAD than in a validation report. The recurring offenders:
- Blind lumens and dead-end channels that cannot be flushed. A through-channel with a flush port at each end is far easier to validate than a closed pocket.
- Narrow, long lumens where the length-to-diameter ratio defeats brushing and flow.
- Hinges, ratchets, and box joints that trap soil closed and must be reprocessed open.
- Mated flat surfaces and press fits that wick fluid by capillary action and never dry.
- Rough or porous finishes, including as-printed additive surfaces, which hold soil mechanically.
- Non-removable seals, which trap residue at their interfaces and degrade under repeated thermal and chemical exposure. Our guide to O-ring selection and gland design covers the fundamentals.
- Tool-required disassembly, which staff will skip. Anything that must come apart for cleaning should come apart by hand and reassemble one obvious way.
Material compatibility over the full reprocessing life
Cleaning validation proves the device gets clean once. Material compatibility proves it survives being cleaned hundreds of times. Enzymatic and alkaline detergents attack some plastics and anodized coatings, disinfectants embrittle certain elastomers, and repeated steam cycles cause dimensional drift and stress cracking in amorphous polymers.
Run a simulated-use study to the maximum number of cycles you intend to claim, then verify the device still meets its performance specification, still passes electrical safety, still seals, and still cleans. The claim in your instructions, whether a cycle count or an inspection-based retirement criterion, must be the number you tested. Our guide to choosing materials for a new product is a useful starting point.
Where it lands in the submission
Reprocessing validation reports and the reprocessing section of the instructions for use are expected in a 510(k) submission for any reusable device, and incomplete data is a routine cause of additional information requests. The instructions need the same care as the data, since a validated process described ambiguously will not be followed; our guide to writing instructions for use covers how to make them usable by processing staff.
If all of this reads as expensive, that is the correct conclusion, and it is why the reusable-versus-disposable decision deserves real analysis. Our article on single-use versus reusable medical devices lays out the economics, and our piece on surgical instrument development covers the design side.
Projects House designs reusable medical devices for reprocessing from the first concept and manages cleaning, disinfection, and material compatibility validation with accredited labs. Tell us about your device through our contact form.